For research use only. Not for therapeutic Use.
Tepoditamab（Cat No.:I042206）is a monoclonal antibody designed to target and inhibit the epidermal growth factor receptor (EGFR) family, specifically focusing on the EGFRvIII variant, which is commonly found in certain cancers, including glioblastoma and non-small cell lung cancer (NSCLC). This variant is associated with tumor growth, resistance to treatment, and poor prognosis. Tepoditamab works by binding to EGFRvIII, blocking its signaling pathways, and potentially enhancing the body’s immune response against cancer cells. It is being studied in clinical trials to evaluate its safety, efficacy, and potential in treating EGFRvIII-positive cancers.
| Catalog Number | I042206 |
| CAS Number | 2044679-53-8 |
| Purity | ≥95% |
